Virtus ETF Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

Virtus ETF Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,985	Closed	-$396K	–	529
2019 Q3	$396K	Sell	20,985 -1,169	-5%	-$13.4K	0.08%	189
2019 Q2	$261K	Buy	+22,154	New	+$268K	0.06%	265
2016 Q4	–	Sell	-8,582	Closed	-$281K	–	202
2016 Q3	$281K	Hold	8,582	–	–	0.14%	105
2016 Q2	$214K	Buy	8,582 +1,309	+18%	+$35.4K	0.16%	130
2016 Q1	$178K	Sell	7,273 -455	-6%	-$10.5K	0.25%	101
2015 Q4	$255K	Buy	+7,728	New	+$261K	0.7%	63

Virtus ETF Advisers's ALDR Position: Q4 2019 in Review

Virtus ETF Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 20,985 shares — an estimated $396K sold.

Virtus ETF Advisers first reported a position in ALDR in Q4 2015 and held it in 6 quarters. The position peaked at $396K in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Virtus ETF Advisers reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Virtus ETF Advisers sold 20,985 Alder Biopharmaceuticals shares in Q4 2019, an estimated $396K.
Virtus ETF Advisers first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 6 quarters.
Virtus ETF Advisers's Alder Biopharmaceuticals position peaked at $396K in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Virtus ETF Advisers's 13F filing for Q4 2019, filed 13 Feb 2020.